ALACHUA, Fla., Dec. 7 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. (Amex: TTG), a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report financial results for the fourth quarter and fiscal-year 2007 ended September 30, 2007 on Monday, December 10, 2007 at 4:30 p.m. ET.
Interested parties can access the call by dialing (888) 408-9532 or (706) 679-5064 or by accessing the web cast at http://www.tutogen.com/investor.aspx. A replay of the call will be available at (800) 642-1687 or (706) 645-9291, conference ID number: 19673685 for 3 days following the call, and the web cast can be accessed at http://www.tutogen.com/investor.aspx for 30 days.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products
made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes
its Tutoplast Process(R) of tissue preservation and viral inactivation to
manufacture and deliver sterile bio-implants used in spinal/trauma,
urology, dental, ophthalmology, and general surgery procedures. The
Company's Tutoplast(R) products are sold and distributed worldwide by
Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc.,
Davol Inc. subsidiary of C.R. Bard Inc., the Mentor Corporation (Mentor),
Coloplast Corp., IOP, Inc. and through independent distributors
internationally. For more information, visit the Company's Web site at
L. Robert Johnston, Jr. Lytham Partners, LLC
Chief Financial Officer Joe Diaz
Tutogen Medical, Inc. Joe Dorame
386-462-0402 Robert Blum
|SOURCE Tutogen Medical, Inc.|
Copyright©2007 PR Newswire.
All rights reserved